Hala Mirza
@halamirzaBiopharma Corporate Affairs. Working mom. All tweets are my own.
Similar User
@whysirsf
@AmyDMarcus
@ronanmadigan
Three Point Champion New Rochelle's Kaz Mirza. @NewRochelleED @KDJmedia1 @lohudhoopsmbd
Congratulations @mirza_kas Not only one of the Top Players in Section 1, but one of the Top Student as well!!!📚📚🏀
Congratulations to our 2024 Court of Excellence Honorees! These tremendous student-athletes will be honored at our annual dinner on March 19th. @KDJmedia1 @DirectRays @lohudhoopsmbd
Vote for Kas Mirza! A great basketball player and the kid that calls me "Mama Bro" lohud.com/story/sports/h…
The U.S. @FDA has approved a new treatment for adults living with polyneuropathy of hereditary transthyretin-mediated amyloidosis. Learn more about this news: ir.ionispharma.com/news-releases/… #RareDisease
Kas Mirza 6’5 24 New Rochelle H.S. Is a catch and shoot range specialist. Mirza has a very very good pump fake pull up game. He will jump on coaches radar soon he is efficient with size and moves with out the ball. Scholarship player for sure. #StockRiser📈 #Sleeper
Reminder: Our investigational antibody cocktail for #COVID19 is FREE to patients who qualify under the Emergency Use Authorization parameters (just like the vaccines are)
#COVID19 news: We’re announcing new positive Phase 3 data demonstrating the effect of our investigational antibody cocktail in reducing risk of hospitalization or death, and duration of symptoms in non-hospitalized patients with COVID-19: bit.ly/31mUZb7
Hear @DavidAKesslerMD, who is leading the federal #COVID19 response, on the value of currently available antibody treatments for mild-to-moderate high-risk patients.
"If you test positive and are at high risk, it's very important to ask your provider about getting monoclonal antibodies," Dr. Kessler says about high risk, Covid-19 patients. "You need to be treated early, within 10 days of symptoms, before hospitalization."
#COVID19 news: Our investigational antibody cocktail was shown in vitro to successfully neutralize #SARSCoV2 variants first identified in the UK and South Africa. @Columbia Read more: bit.ly/39osbDy
If you or your patient has been recently diagnosed with #COVID19 and meets certain high-risk criteria, find out where monoclonal antibody therapies may be available in your area: bit.ly/3pQ2TDK (via @HHSGov)
Once again, we’ve been included on the 2020 #DJSI World Index. As one of only four companies in our sector to be included on this year’s list, this recognition reflects our dedication to building a better world. #ResponsibleRegeneron
14) Thanks for reading, & for taking a minute to learn more about Regeneron beyond the memes! Here are a few other things – besides our COVID-19 efforts – that we were particularly proud of this year.
1) A lot of you are just getting to know #Regeneron – welcome, and perhaps it’s time to clear a few things up… (thread)
Today, our colleagues discussed their #career journeys and work at Regeneron with the 2020 #RegeneronSTS finalists during the virtual Innovation Panel moderated by @halamirza CC: @Society4Science
#RegeneronISEF is bringing the best #science and #engineering right into your home. Tune in throughout the week to hear experts speak on a variety of topics, including technology and #STEM education. To learn more, visit: bit.ly/2ydnOeS CC: @Society4Science
Here's what's coming your way over the next couple of days at Virtual #RegeneronISEF! bit.ly/3bhTWM3
Our CSO George Yancopoulos discussed on @CNNi how we’re applying lessons from our #Ebola research to finding a potential medicine for #COVID19. Watch via w/ @jchatterleyCNN
A #PassiveVaccine for #COVID19? What about a drug that might mean less ventilator use? Biotech giant @Regeneron is working on both. A fascinating convo with Dr. George Yancopolous CSO, on the science race to save lives. #CoronavirusOutbreak
Update on our #COVID19 novel antibody program: We’ve identified hundreds of virus-neutralizing antibodies from our VelocImmune technology and are now selecting the top candidates for clinical testing. Learn more: bit.ly/2WoBm0P
It's all-hands-on-deck at pharmaceutical companies around the world as the coronavirus spreads. I visited Regeneron, a company that's racing to develop a drug and has been successful in the past at treating Ebola.
Inside a lab racing to develop treatment for the coronavirus: nbcnews.to/339D8nK @LesterHoltNBC reports.
We're proud to support this important legislation & the leadership of @NYGov in fighting intolerance, ignorance & hate.
.@NYGovCuomo’s #NoHateInOurState campaign includes: -First-in-the-nation domestic terrorism law -$25M for religious nonprofits vulnerable to hate crimes -Education curriculum on diversity and tolerance -$2M to support Hate Crimes Task Force governor.ny.gov/programs/no-ha…
Announcing our expanded collaboration with @HHSGov to develop new potential antibody medicines for the novel #coronavirus. Learn more: bit.ly/2OrUgz2.
United States Trends
- 1. #TheGameAwards 295 B posts
- 2. Deebo 25,5 B posts
- 3. Purdy 15,1 B posts
- 4. Naughty Dog 21,5 B posts
- 5. 49ers 39,2 B posts
- 6. Clive 26,9 B posts
- 7. Rams 32,4 B posts
- 8. Cooper Kupp 3.186 posts
- 9. Stafford 11,3 B posts
- 10. Okami 22,9 B posts
- 11. Niners 7.109 posts
- 12. Elden Ring 133 B posts
- 13. $LINGO 67,1 B posts
- 14. Kittle 7.033 posts
- 15. Arcane 253 B posts
- 16. Ciri 40,6 B posts
- 17. Fallout 30,7 B posts
- 18. Witcher 4 37,4 B posts
- 19. Geoff 25,2 B posts
- 20. Tifa 18,5 B posts
Something went wrong.
Something went wrong.